Market Research Logo

GW Pharmaceuticals plc - Product Pipeline Review - 2015

GW Pharmaceuticals plc - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘GW Pharmaceuticals plc - Product Pipeline Review - 2015’, provides an overview of the GW Pharmaceuticals plc’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of GW Pharmaceuticals plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note:* Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of GW Pharmaceuticals plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of GW Pharmaceuticals plc’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the GW Pharmaceuticals plc’s pipeline products
Reasons to buy
  • Evaluate GW Pharmaceuticals plc’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of GW Pharmaceuticals plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the GW Pharmaceuticals plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of GW Pharmaceuticals plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of GW Pharmaceuticals plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of GW Pharmaceuticals plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


GW Pharmaceuticals plc Snapshot
GW Pharmaceuticals plc Overview
Key Information
Key Facts
GW Pharmaceuticals plc - Research and Development Overview
Key Therapeutic Areas
GW Pharmaceuticals plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
GW Pharmaceuticals plc - Pipeline Products Glance
GW Pharmaceuticals plc - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
GW Pharmaceuticals plc - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
GW Pharmaceuticals plc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
GW Pharmaceuticals plc - Drug Profiles
Epidiolex
Product Description
Mechanism of Action
R&D Progress
nabiximols
Product Description
Mechanism of Action
R&D Progress
GWP-42003
Product Description
Mechanism of Action
R&D Progress
GWP-42004
Product Description
Mechanism of Action
R&D Progress
GWP-42006
Product Description
Mechanism of Action
R&D Progress
(GWP-42002 + GWP-42003)
Product Description
Mechanism of Action
R&D Progress
GW Pharmaceuticals plc - Pipeline Analysis
GW Pharmaceuticals plc - Pipeline Products by Target
GW Pharmaceuticals plc - Pipeline Products by Route of Administration
GW Pharmaceuticals plc - Pipeline Products by Molecule Type
GW Pharmaceuticals plc - Pipeline Products by Mechanism of Action
GW Pharmaceuticals plc - Recent Pipeline Updates
GW Pharmaceuticals plc - Dormant Projects
GW Pharmaceuticals plc - Company Statement
GW Pharmaceuticals plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
GW Pharmaceuticals plc, Key Information
GW Pharmaceuticals plc, Key Facts
GW Pharmaceuticals plc - Pipeline by Indication, 2015
GW Pharmaceuticals plc - Pipeline by Stage of Development, 2015
GW Pharmaceuticals plc - Monotherapy Products in Pipeline, 2015
GW Pharmaceuticals plc - Combination Treatment Modalities in Pipeline, 2015
GW Pharmaceuticals plc - Phase III, 2015
GW Pharmaceuticals plc - Phase II, 2015
GW Pharmaceuticals plc - Phase I, 2015
GW Pharmaceuticals plc - Preclinical, 2015
GW Pharmaceuticals plc - Pipeline by Target, 2015
GW Pharmaceuticals plc - Pipeline by Route of Administration, 2015
GW Pharmaceuticals plc - Pipeline by Molecule Type, 2015
GW Pharmaceuticals plc - Pipeline Products by Mechanism of Action, 2015
GW Pharmaceuticals plc - Recent Pipeline Updates, 2015
GW Pharmaceuticals plc - Dormant Developmental Projects,2015
GW Pharmaceuticals plc, Other Locations
GW Pharmaceuticals plc, Subsidiaries
List of Figures
GW Pharmaceuticals plc - Pipeline by Top 10 Indication, 2015
GW Pharmaceuticals plc - Pipeline by Stage of Development, 2015
GW Pharmaceuticals plc - Monotherapy Products in Pipeline, 2015
GW Pharmaceuticals plc - Pipeline by Top 10 Target, 2015
GW Pharmaceuticals plc - Pipeline by Top 10 Route of Administration, 2015
GW Pharmaceuticals plc - Pipeline by Top 10 Molecule Type, 2015
GW Pharmaceuticals plc - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report